Skip to main content
Premium Trial:

Request an Annual Quote

Herbert Fritsche, James Mullen

Premium

Herbert Fritsche has joined the scientific advisory board of Health Discovery, of Waco Texas. Fritsche is currently a professor of laboratory medicine and chief of the clinical chemistry section at The University of Texas, M.D. Anderson Cancer Center in Houston, where he has been a researcher for 35 years. Health Discovery is a discovery company that uses computational modeling to identify diagnostic and therapeutic targets.


James Mullen has been elected to the board of directors of PerkinElmer. Mullen is CEO of Biogen Idec. He was formerly chairman of the board and CEO of Biogen. He has also served at Biogen as president; director of facilities and engineering; vice president of operations; and vice president international. Prior to joining Biogen, Mullen had various positions at SmithKline Beecham. He holds a BS in chemical engineering from Rensselaer Polytechnic Institute and an MBA from Villanova University.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.